Cargando…

CHRM3 is a novel prognostic factor of poor prognosis and promotes glioblastoma progression via activation of oncogenic invasive growth factors

Glioblastoma (GBM) is the most aggressive cancer of the brain and has a high mortality rate due to the lack of effective treatment strategy. Clarification of molecular mechanisms of GBM’s characteristic invasive growth is urgently needed to improve the poor prognosis. Single-nuclear sequencing of pr...

Descripción completa

Detalles Bibliográficos
Autores principales:	ZHANG, BIN, ZHAO, JIANYI, WANG, YONGZHI, XU, HUA, GAO, BO, ZHANG, GUANGNING, HAN, BIN, SONG, GUOHONG, ZHANG, JUNCHEN, MENG, WEI
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Tech Science Press 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10513942/ https://www.ncbi.nlm.nih.gov/pubmed/37744266 http://dx.doi.org/10.32604/or.2023.030425

Ejemplares similares

Polymorphisms in the Cholinergic Receptors Muscarinic (CHRM2 and CHRM3) Genes and Alzheimer’s Disease
por: Chee, Lim Ya, et al.
Publicado: (2018)

Nerve growth factor interacts with CHRM4 and promotes neuroendocrine differentiation of prostate cancer and castration resistance
por: Chen, Wei-Yu, et al.
Publicado: (2021)

Pancreas-specific CHRM3 activation causes pancreatitis in mice
por: Wan, Jianhua, et al.
Publicado: (2021)

Sex, Age, and Regional Differences in CHRM1 and CHRM3 Genes Expression Levels in the Human Brain Biopsies: Potential Targets for Alzheimer's Disease-related Sleep Disturbances
por: Sanfilippo, Cristina, et al.
Publicado: (2023)

EGFLAM correlates with cell proliferation, migration, invasion and poor prognosis in glioblastoma
por: Chen, Juhui, et al.
Publicado: (2019)

Six-Transmembrane Epithelial Antigen of Prostate 3 Predicts Poor Prognosis and Promotes Glioblastoma Growth and Invasion
por: Han, Mingzhi, et al.
Publicado: (2018)

BMI-1 promotes invasion and metastasis in endometrial adenocarcinoma and is a poor prognostic factor
por: Yu, Jing, et al.
Publicado: (2020)

MicroRNA-30e inhibits adhesion, migration, invasion and cell cycle progression of prostate cancer cells via inhibition of the activation of the MAPK signaling pathway by downregulating CHRM3
por: Zheng, Xin-Min, et al.
Publicado: (2018)

BMI-1 promotes invasion and metastasis in endometrial adenocarcinoma and is a poor prognostic factor
por: Yu, Jing, et al.
Publicado: (2022)

Network toxicology and molecular docking analyses on strychnine indicate CHRM1 is a potential neurotoxic target
por: Dai, Jialin, et al.
Publicado: (2022)

MicroRNA-384 inhibits proliferation migration and invasion of glioma by targeting at CDC42
por: Gu, Gengshi, et al.
Publicado: (2018)

A regulatory variant of CHRM3 is associated with cannabis-induced hallucinations in European Americans
por: Cheng, Zhongshan, et al.
Publicado: (2019)

A homozygous missense variant in CHRM3 associated with familial urinary bladder disease
por: Beaman, Glenda M., et al.
Publicado: (2019)

EP300 as an oncogene correlates with poor prognosis in esophageal squamous carcinoma
por: Bi, Yanghui, et al.
Publicado: (2019)

Epilepsy in Adults with Supratentorial Glioblastoma: Incidence and Influence Factors and Prophylaxis in 184 Patients
por: Liang, Shuli, et al.
Publicado: (2016)

Overexpression of a novel candidate oncogene KIF14 correlates with tumor progression and poor prognosis in prostate cancer
por: Zhang, Yixiang, et al.
Publicado: (2017)

CRM1, a novel independent prognostic factor overexpressed in invasive breast carcinoma of poor prognosis
por: Yue, Lu, et al.
Publicado: (2018)

Hypomethylation of 111 Probes Predicts Poor Prognosis for Glioblastoma
por: Chen, Qi, et al.
Publicado: (2019)

EPS8 is a Potential Oncogene in Glioblastoma
por: Yang, Gang, et al.
Publicado: (2019)

Correlation of Clinicopathological Factors with Brain Tumor-Related Epilepsy in Glioma
por: Wang, Zengliang, et al.
Publicado: (2022)

Galectin-1 is a poor prognostic factor in patients with glioblastoma multiforme after radiotherapy
por: Chou, Shang-Yu, et al.
Publicado: (2018)

Overexpression of the recently identified oncogene REDD1 correlates with tumor progression and is an independent unfavorable prognostic factor for ovarian carcinoma
por: Chang, Bin, et al.
Publicado: (2018)

Identification of HOXD10 as a Marker of Poor Prognosis in Glioblastoma Multiforme
por: Li, Yanxin, et al.
Publicado: (2021)

miR-888 functions as an oncogene and predicts poor prognosis in colorectal cancer
por: Gao, Su-Jun, et al.
Publicado: (2018)

KCNH3 Predicts Poor Prognosis and Promotes Progression in Ovarian Cancer
por: Li, Zhongjun, et al.
Publicado: (2020)

High Expression of CD44 Predicts a Poor Prognosis in Glioblastomas
por: Si, Daolin, et al.
Publicado: (2020)

Correlation of IDH1 Mutation with Clinicopathologic Factors and Prognosis in Primary Glioblastoma: A Report of 118 Patients from China
por: Yan, Wei, et al.
Publicado: (2012)

High expression of oncogene cadherin-6 correlates with tumor progression and a poor prognosis in gastric cancer
por: Zhao, Zongxian, et al.
Publicado: (2021)

Association between glioblastoma cell‐derived vessels and poor prognosis of the patients
por: Mei, Xin, et al.
Publicado: (2020)

Genomic Analysis of Glioblastoma Multiforme Reveals a Key Transcription Factor Signature Relevant to Prognosis and the Immune Processes
por: Li, Zhen-Hang, et al.
Publicado: (2021)

Overexpression of colorectal cancer oncogene CHRDL2 predicts a poor prognosis
por: Sun, Jian, et al.
Publicado: (2016)

UBR5 oncogene as an indicator of poor prognosis in gastric cancer
por: Ding, Fanghui, et al.
Publicado: (2020)

High expression of serine and arginine-rich splicing factor 9 (SRSF9) is associated with hepatocellular carcinoma progression and a poor prognosis
por: Zhang, Guoshun, et al.
Publicado: (2022)

Association of sirtuin-1 and vascular endothelial growth factor expression with tumor progression and poor prognosis in liposarcoma
por: Wu, Hongzeng, et al.
Publicado: (2020)

High Apelin Level Indicates a Poor Prognostic Factor in Muscle-Invasive Bladder Cancer
por: Yang, Long, et al.
Publicado: (2019)

CHRM4/AKT/MYCN upregulates interferon alpha-17 in the tumor microenvironment to promote neuroendocrine differentiation of prostate cancer
por: Wen, Yu-Ching, et al.
Publicado: (2023)

Retraction: Receptor tyrosine kinase AXL is correlated with poor prognosis and induces temozolomide resistance in glioblastoma
por: Wang, Jia, et al.
Publicado: (2019)

Prognosis Research Strategy (PROGRESS) 2: Prognostic Factor Research
por: Riley, Richard D., et al.
Publicado: (2013)

Identification of CTRP1 as a Prognostic Biomarker and Oncogene in Human Glioblastoma
por: Chen, Liyan, et al.
Publicado: (2019)

WNT6 is a novel oncogenic prognostic biomarker in human glioblastoma
por: Gonçalves, Céline S., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_3ui2iek79lt1pd1grd9np56ces